3-Indoleacetonitrile CAS 771-51-7 Bohloeki >99.0% (HPLC) Factory High Quality

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: 3-Indoleacetonitrile

CAS: 771-51-7

Bohloeki: >99.0% (HPLC)

Ponahalo: Bosehla bo Khanyang ho ea ho Phofo e Sootho e Khanyang

Boleng bo Phahameng, Tlhahiso ea Khoebo

E-Mail: alvin@ruifuchem.com

Re romelle lengolo-tsoibila

Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Shanghai Ruifu Chemical Co., Ltd. ke moetsi ea ka sehloohong le mofani oa thepa ea 3-Indoleacetonitrile (CAS: 771-51-7) e nang le boleng bo phahameng, tlhahiso ea khoebo.O amohetsoe ho odara.

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale	3-Indoleacetonitrile
Litlhaloso tse tšoanang	Indole-3-Acetonitrile;2-(1H-Indol-3-yl)acetonitrile
Nomoro ea CAS	771-51-7
Nomoro ea KAtse	RF-PI1602
Boemo ba Setoko	Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule	C10H8N2
Boima ba Molek'hule	156.19
Melting Point	33.0 ~ 36.0℃ (lit.)
Botenya	1.1566
Solubility	E qhibiliha ka Methanol (Hoo e batlang e le Transparency)
Brand	Ruifu Chemical

Litlhaloso:

Ntho	Litlhaloso
Ponahalo	Phofo e Bosehla bo Khanyang ho isa ho Bosootho bo Khanyang
Mokhoa oa Bohloeki / Analysis	>99.0% (HPLC)
Tahlehelo ka ho Omisa	<1.00%
Tšilafalo e le Mong	<0.50%
Litšila ka Kakaretso	<1.00%
1 H NMR Spectrum	E Lumellanang le Sebopeho
Tekanyetso ea Teko	Maemo a Khoebo
Tšebeliso	Mekhatlo ea Meriana

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo.

Melemo:

LBH:

Kopo:

3-Indoleacetonitrile (CAS: 771-51-7),Reactant bakeng sa ho lokisetsa: Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles e le li-immunomodulators tse ka 'nang tsa e-ba khahlanong le kankere;Histone deacetylase inhibitors;Li-inhibitors tse ka bang teng tsa kinase;Li-activators tsa potassium tsa Kv7/KCNQ;Kinesin-Specific MKLP-2 Inhibitor;Meriana e bolaeang likokoanyana;Lisebelisoa tse ka bang teng tsa ho etsa litšoantšo tsa mofetše oa PET;Agonists ea Farnesoid X Receptor (FXR) e le phekolo ea atherosclerosis;butyrylcholinesterase inhibitors;Li-inhibitors tsa Necroptosis.